JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Compare Psoriasis medicines

Compare Psoriasis medicines

Bimzelx (bimekizumab-bkzx) vs Simlandi (adalimumab-ryvk)

Ilumya (tildrakizumab) vs Bimzelx (bimekizumab-bkzx)

Ilumya (tildrakizumab) vs Simlandi (adalimumab-ryvk)

Ilumya (tildrakizumab) vs Skyrizi (risankizumab)

Ilumya (tildrakizumab) vs Sotyktu (deucravacitinib)

Ilumya (tildrakizumab) vs Wezlana (ustekinumab-auub)

Ilumya (tildrakizumab) vs Zoryve (roflumilast)

Skilarence (dimethyl fumarate) vs Bimzelx (bimekizumab-bkzx)

Skilarence (dimethyl fumarate) vs Ilumya (tildrakizumab)

Skilarence (dimethyl fumarate) vs Simlandi (adalimumab-ryvk)

Skilarence (dimethyl fumarate) vs Skyrizi (risankizumab)

Skilarence (dimethyl fumarate) vs Sotyktu (deucravacitinib)

Skilarence (dimethyl fumarate) vs Stelara (ustekinumab)

Skilarence (dimethyl fumarate) vs Tremfya (guselkumab)

Skilarence (dimethyl fumarate) vs Wezlana (ustekinumab-auub)

Skilarence (dimethyl fumarate) vs Zoryve (roflumilast)

Skyrizi (risankizumab) vs Bimzelx (bimekizumab-bkzx)

Skyrizi (risankizumab) vs Simlandi (adalimumab-ryvk)

Skyrizi (risankizumab) vs Sotyktu (deucravacitinib)

Skyrizi (risankizumab) vs Wezlana (ustekinumab-auub)

Skyrizi (risankizumab) vs Zoryve (roflumilast)

Sotyktu (deucravacitinib) vs Bimzelx (bimekizumab-bkzx)

Sotyktu (deucravacitinib) vs Simlandi (adalimumab-ryvk)

Sotyktu (deucravacitinib) vs Wezlana (ustekinumab-auub)

Stelara (ustekinumab) vs Bimzelx (bimekizumab-bkzx)

Stelara (ustekinumab) vs Ilumya (tildrakizumab)

Stelara (ustekinumab) vs Simlandi (adalimumab-ryvk)

Stelara (ustekinumab) vs Skyrizi (risankizumab)

Stelara (ustekinumab) vs Sotyktu (deucravacitinib)

Stelara (ustekinumab) vs Wezlana (ustekinumab-auub)

Stelara (ustekinumab) vs Zoryve (roflumilast)

Taltz (ixekizumab) vs Bimzelx (bimekizumab-bkzx)

Taltz (ixekizumab) vs Ilumya (tildrakizumab)

Taltz (ixekizumab) vs Simlandi (adalimumab-ryvk)

Taltz (ixekizumab) vs Skilarence (dimethyl fumarate)

Taltz (ixekizumab) vs Skyrizi (risankizumab)

Taltz (ixekizumab) vs Sotyktu (deucravacitinib)

Taltz (ixekizumab) vs Stelara (ustekinumab)

Taltz (ixekizumab) vs Tremfya (guselkumab)

Taltz (ixekizumab) vs Wezlana (ustekinumab-auub)

Taltz (ixekizumab) vs Zoryve (roflumilast)

Tremfya (guselkumab) vs Bimzelx (bimekizumab-bkzx)

Tremfya (guselkumab) vs Ilumya (tildrakizumab)

Tremfya (guselkumab) vs Simlandi (adalimumab-ryvk)

Tremfya (guselkumab) vs Skyrizi (risankizumab)

Tremfya (guselkumab) vs Sotyktu (deucravacitinib)

Tremfya (guselkumab) vs Stelara (ustekinumab)

Tremfya (guselkumab) vs Wezlana (ustekinumab-auub)

Tremfya (guselkumab) vs Zoryve (roflumilast)

Wezlana (ustekinumab-auub) vs Bimzelx (bimekizumab-bkzx)

Wezlana (ustekinumab-auub) vs Simlandi (adalimumab-ryvk)

Zoryve (roflumilast) vs Bimzelx (bimekizumab-bkzx)

Zoryve (roflumilast) vs Simlandi (adalimumab-ryvk)

Zoryve (roflumilast) vs Sotyktu (deucravacitinib)

Zoryve (roflumilast) vs Wezlana (ustekinumab-auub)

US 0